Nu Skin: Patience Is Still Advised
2026-02-25 11:49:00 ET
Heading into an important year, there is a case on paper for Nu Skin Enterprises ( NUS ) stock. Shares are cheap, trading in the range of 3x adjusted EBITDA for 2026. Guidance for this year does seem to have disappointed, sending shares lower, but margins appear set to expand, and the company expects revenue growth to turn positive toward the tail end of the year....
Read the full article on Seeking Alpha
For further details see:
Nu Skin: Patience Is Still AdvisedNASDAQ: HLF
HLF Trading
-3.07% G/L:
$15.80 Last:
641,983 Volume:
$15.73 Open:



